Home › Products › Oncology › Cytaright 500mg Injection
Cytaright 500mg Injection
Salt Composition: CYTARABINE
- Manufacturer: METTA LIFE SCIENCES PVT LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 500MG
- Prescription Required
- Storage: Store Cytaright 500mg Injection at room temperature (25°C) Do not refrigerate or freeze. Keep the injection away from the reach of children and pets. If you forgot to take a dose on the scheduled day, contact your physician and reschedule the dose. Do not take a double dose to make up for a forgotten dose.
₹280.00₹350.00
Inclusive of all taxes
Product Introduction
Cytaright 500mg Injection contains the active substance Cytarabine. It is an antineoplastic drug belonging to the class of antimetabolites. It is used alone or in combination with other chemotherapy medications to treat certain types of leukaemias (a type of blood cancer characterised by an excess of white blood cells), including acute myeloid leukaemia (AML) and chronic myelogenous leukaemia (CML). It is also indicated for use alone or in combination with other chemotherapy drugs to treat and prevent meningeal leukaemia (cancer affecting the membrane that covers and protects the spinal cord and brain). Do not take Cytaright 500mg Injection if you are allergic to Cytarabine or any other ingredients in this medicine. Inform your physician if you have difficulties with body coordination, are taking any other anti-cancer medications, have decreased bone marrow functioning, have liver problems, or have undergone dialysis immediately before or after treatment with this medicine. This medicine may cause an increased uric acid level in your blood. Your doctor will advise you if you require any medicine to control this. Notify your physician if you experience sudden signs of allergy, such as rash, itching, or hives on the skin, swelling of the face, lips, mouth, or throat, shortness of breath, or wheezing. Safety and efficacy in patients with kidney failure have not been established. Inform your doctor if you have any kidney diseases.
Uses
Cytaright 500mg Injection is used in the treatment of the following: Acute myeloid leukemia (AML) Chronic myelogenous leukemia (CML) Meningeal leukaemia
How it works
Cytaright 500mg Injection is a cytotoxic drug that acts by primarily killing cells undergoing DNA synthesis. It works by slowing or stopping the growth of cancer cells in your body.
How to Use
Cytaright 500mg Injection will be given to you in a hospital setting by a trained healthcare professional. This medicine may be given by solution for injection/infusion (using a syringe) under the skin (subcutaneous) into a vein (intravenously) into a muscle (intramuscularly) or the spine (intrathecal). Your doctor will decide the dose, route of administration, and duration of the treatment based on your disease condition, severity, and other factors.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common side effects of the Cytaright 500mg Injection are: Fever Loss of appetite, abdominal pain Swallowing difficulties Nausea, vomiting Diarrhoea Inflammation or ulceration in the mouth or anus High blood uric acid levels Hair loss Skin rashes Speaking difficulties Inflammation in the vein Serious side effects of the Cytaright 500mg Injection are: Swelling and irritation of the skin Increased blood uric acid levels Blisters of the skin Irregular heartbeat Lung diseases Anemia Infection Kidney problems
Expert Tips
During the treatment with Cytaright 500mg Injection, administration of vaccines is not advised. If required, consult your doctor. This medicine may cause infertility in men and women. Your doctor will do blood tests regularly to check whether the medicine works. Inform your physician if you have any ulcers or bleeding in the stomach or intestines. This medicine may make you bleed or bruise easily; take precautions to prevent the illness.
References
- Cytarabine Injection. [cited 2020 Dec 3]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/071868s032lbl.pdf
- Cytarabine Injection Solution 100 mg/ml - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. [revised on 2020] [cited 2023 Mar 30]. Available from: https://www.medicines.org.uk/emc/product/1570/smpc
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1698 â 1699.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 864 - 865.
Safety Advice
Pregnancy: unsafe Cytaright 500mg Injection is unsafe to administer in pregnant women because it may cause birth defects. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 6 months after your last dose is necessary.
Lungs: Consult your doctor It is unknown whether Cytaright 500mg Injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Cytaright 500mg Injection because the medicine passes into the breast milk in small amounts and may harm your baby.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.